Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

Open access

Abstract

Objective Evaluation of clinical and endocrine effects of naltrexone administration in obese women with PCOS. Design Open, controlled, clinical study. Setting Department of Reproductive Medicine and Child Development, Section of Gynecology and Obstetrics, University of Pisa, Pisa, Italy. Patient(s) Ten PCOS women were studied. Intervention(s) Women were treated with naltrexone (50 mg/day) for 6 months. Main outcome measure(s) Body mass index and the menstrual cyclicity during naltrexone treatment were assessed. Basal levels of LH, FSH, 17beta-estradiol (E(2)), 17-hydroxyprogesterone, total and free T, androstenedione, dehydroepiandrosterone sulfate, cortisol, sex hormone-binding globulin were evaluated before treatment and every 3 months. Progesterone levels were measured in the luteal phase during the sixth month. Gonadotropin response to GnRH administration (10 microg) and a 75-g oral glucose tolerance test were performed before and every 3 months. Result(s) Body mass index significantly decreased from 29.94 +/- 1.04 to 26.07 +/- 0.81 during treatment. The menstrual cyclicity improved in 80% of PCOS women: the mean cycle length was 40-360 days before treatment and ranged between 25 and 120 days and 28-120 days after 3 and 6 months of treatment. Plasma levels of free T, androstenedione, dehydroepiandrosterone sulfate, and cortisol significantly decreased. Fasting glucose-to-insulin ratio improved in women with insulin resistance. Conclusion(s) Naltrexone may have a beneficia…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(02)02955-2

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 2

  1. Lanzone, 1995, Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome, J Clin Endocrinol Metab, 80, 3501
  2. Cozzolino, 1996, The involvementof the opioid system in human obesity, J Clin Endocrinol Metab, 81, 713

Cited by

See all 62

Metadata

Authors
Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., & Genazzani, A. R.
Affiliations
University of Pisa (IT)
Corresponding author
  • Fruzzetti, Franca
  • Genazzani, Andrea Riccardo
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2002-05
Volume
77
Issue
5
Pages
936-944
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2046547866
Cited by
62
References
38
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 2 · 2013: 4 · 2012: 5
FWCI
3.03
Type
journal article
Language
en
Open access
Licence
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
naltrexone, polycystic ovary syndrome, obesity, insulin resistance, menstrual cyclicity, body mass index, gonadotropins, sex hormones, androstenedione, dehydroepiandrosterone sulfate, cortisol, thyroid hormones, GnRH stimulation, weight loss
MeSH terms
Adult, Androgens, Blood Glucose, Drug Administration Schedule, Endocrine Glands, Fasting, Female, Gonadotropins, Humans, Hydrocortisone, Insulin, Insulin Resistance, Menstrual Cycle, Naltrexone, Narcotic Antagonists, Obesity, Polycystic Ovary Syndrome, Time Factors, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1016/s0015-0282(02)02955-2
The paper
Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., & Genazzani, A. R. (2002). Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertility and Sterility. https://doi.org/10.1016/s0015-0282(02)02955-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.